Scienture (SCNX) announced that Suren Ajjarapu, who has served as Chief Executive Officer and Chairman of the Board of Directors, has stepped down from his roles with the Company, with those positions being assumed by the existing, experienced management team of Dr. Shankar Hariharan and Dr. Narasimhan Mani. Shankar Hariharan, Ph.D – Executive Chairman of the BOD and Co-CEO; Narasimhan Mani, Ph.D., MBA – President and Co-CEO; Member of the BOD
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SCNX:
- Scienture Holdings Terminates Agreement with Arena Business
- Scienture announces FDA Orange Book patent listing for Arbli
- Scienture initiates supply chain activities by subsidiary to launch Arbli
- Scienture Holdings Divests Subsidiaries to Tollo Health
- Scienture divests Integra Pharma Solutions, Bonum Health, Softell for $5M